Everything tagged "specialty chemicals" across the TickerSpark archives.
H.B. Fuller is showing improving margins, solid cash generation, and a credible medical adhesives growth story. Leverage and acquisition integration risk keep the stock in Hold territory despite attractive valuation.
Linde posted record Q2 sales and EPS, backed by an $8.1B backlog and $1B of electronics wins. The stock looks expensive, but its contracted industrial gas model and AI-linked demand keep the Buy case intact.
Solstice Advanced Materials posted 11% revenue growth in 2Q26 and raised full-year guidance, with refrigerants, electronic materials and nuclear services driving the story. Leverage, margin pressure and the Element Solutions deal keep the risk profile elevated.
Seven specialty chemicals stocks ranked by investment quality, with a countdown spanning additives, engineered materials, electronics, energy storage, and process chemicals.
Westlake is a Hold as cost-cutting and a 2026 earnings rebound could help, but weak Q1 results and uneven earnings execution keep the setup cautious.
Ecolab is benefiting from stronger growth in high-tech, life sciences, and pest elimination, with margins improving and AI-related water demand adding a new catalyst. But the stock already trades at a premium, keeping the rating at Hold.
SOLS looks like a stock getting punished for deal shock more than for a broken core business. The acquisition risk is real, but the selloff has run ahead of a company that just posted 10% quarterly sales growth, reaffirmed guidance, and still carries constructive analyst support.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime